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Innovative pharmacological approaches to control the excessive neutrophil inﬁltrates
into the bronchial lumen of CF patients are thought to be beneﬁcial to reduce the
extensive airway tissue damage. The activation of expression of pro-inﬂammatory
genes by P. aeruginosa with bronchial epithelial cells is a central mechanism to
be targeted with novel therapies. Medicinal plants are attracting a growing interest
because of their potential safety, already tested in large scale applications in human
diseases. However, due to the presence of different active principles in each plant
extract, whose multifunctional effects may even result contradictory, understanding
the effect of each component is mandatory to pursue selective and reproducible
applications. A panel of medicinal plant extracts have been ﬁrstly screened for
their capacity to interfere in the binding of nuclear transcription factor proteins (TF)
with DNA consensus sequences identiﬁed in the promoters of the pro-inﬂammatory
genes, thus for their potential inhibitory action on gene expression. Extracts from
Emblica ofﬁcinalis (EO), Aegle marmelos (AM), Polyalthia longifolia (PL) have
been screened for their ability to interfere with the TFs NF-úB, AP-1 and CREB
induced by P. aeruginosa and have been shown to inhibit TF/DNA interactions,
opening the possibility of potential applications to down-regulate expression of pro-
inﬂammatory genes. Extracts from EO, AM, PL were tested in IB3−1 bronchial cells
exposed to the P. aeruginosa PAO1. EO, AM and PL strongly inhibited the PAO1-
dependent transcription of IL-8 in IB3−1 cells. Pyrogallol, one active principle
of EO, was tested in IB3−1 cells, where it inhibited the transcription of IL-8,
GRO-a and g, of ICAM-1 and IL-6, similarly to the whole EO extract, whereas a
second active principle from EO, namely 5-hydroxy-isoquinoline, had no effect. In
conclusion, extracts from plants of the traditional medicine can inhibit expression
of pro-inﬂammatory genes and screening active principles puriﬁed from medicinal
plants could result useful to identify safe and innovative pharmaceutical molecules
to control lung inﬂammation in the lung of CF patients.
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The role of CFTR deﬁciency in promoting inﬂammation remains unclear. It has
been recently reported by Perez et al. that the inhibition of function of w/t CFTR
produces an inﬂammatory proﬁle that resembles that observed in CF patients [Am J
Physiol Lung Cell Mol Physiol, 2007], whereas we demonstrated that correction of
F508del CFTR function with MPB-07 down modulates the P. aeruginosa dependent
expression of the pro-inﬂammatory mediators IL-8 and ICAM-1 in CF bronchial
cells [Am. J. Resp. Cell. Mol Biology, 2007]. Since both evidence support a direct
link between CFTR function and inﬂammation, we extended our investigation to
other F508del CFTR correctors, such as miglustat [FEBS letters, 2006], which is
an approved drug for Gaucher disease, in comparison with an isomer without any
correcting effect, namely NB-DGJ. Miglustat signiﬁcantly reduced the expression
of IL-8 and ICAM-1 in CF bronchial cells IB3−1 and in CuFi-1, upon infection by
PAO1 or stimulation with TNFa or IL-1b and restored CFTR function. Miglustat
had no major effects on overall binding activity of transcription factors NF-kB and
AP-1, activated by PAO1 in these cell lines. NB-DGJ, which is not a corrector of
function of F508del CFTR, down modulated the inﬂammatory response in CF cells.
In addition, both miglustat and NB-DGJ produced the same anti-inﬂammatory effect
in non CF NuLi-1 cells. In conclusion, miglustat is a corrector of F508del CFTR
function in CF bronchial IB3−1 and CuFi-1 cells and has an anti-inﬂammatory
effect which is independent of the correction of F508del CFTR, by interfering with
the pro-inﬂammatory signaling downstream the receptors for pathogens and pro-
inﬂammatory cytokines. Since miglustat is already approved for the treatment of
Gaucher disease and other glycosphingolipidoses, it could represent an interesting
new molecule to ameliorate lung inﬂammation in CF patients.
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Massive inﬁltrates of neutrophils in the mucosal wall and lumen of the conductive
airways of CF patients contribute to the progressive lung function decline by releas-
ing different proteases responsible for the progressive airway tissue damage. Bacte-
rial products and pathogens themselves within the mucopurulent material of the air-
way surface ﬂuid induce the activation of transcription factors such as NF-kappaB,
AP-1, Sp1, NF-IL6, NF-AT, Elk-1, CREB resulting in expression of chemo/cytokine
genes driving the recruitment of leukocytes inside the bronchial lumen. We are
exploring the transcription factor (TF) “decoy” strategy, in which oligodeoxynu-
cleotides (ODN) mimicking the consensus sequences for the TFs proteins identiﬁed
in the promoters of different chemo/cytokines are delivered inside the cell in order
to interfere with gene transcription. CF bronchial epithelial cells IB3−1 have been
exposed to the P. aeruginosa strain PAO1. Transcription of genes involved in innate
immune response has been quantiﬁed by real-time (RT) PCR. Transcription factor
“decoy” ODNs directed against the consensus sequences identiﬁed in the promoters
of different genes have been designed and validated by testing their interference
in TF protein/DNA binding assays. Transfection of IB3−1 cells with HIV-1 LTR
and IgK chain NF-kB ODN “decoys” complexed with Lipofectamine, performed
30 hrs before challenge with PAO1, was shown previously to inhibit strongly PAO1-
dependent transcription of IL-8. Therefore other TF “decoy” ODNs have been also
tested: (a) ODN for NF-kB from IL-8 promoter inhibited IL-8, GRO-gamma and
IL-6; (b) ODN for Sp1 from HIV-1 genome inhibited IL-6; (c) ODN for AP-1 from
IL-8 promoter inhibited both IL-8 and GRO-gamma. In conclusion, transcription
of cytokines in CF bronchial epithelial cells in vitro can be inhibited with different
efﬁciency and selectivity by TF “decoy” molecules. These results provide useful
hints for a gene-targeted anti-inﬂammatory approach and add further information on
the regulation of expression of pro-inﬂammatory genes in bronchial epithelial cells.
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We have demonstrated an important role for NHERF1 in regulating CFTR localiza-
tion and stability on the apical membrane of normal cell monolayers [1]. NHERF1
over-expression in CFBE41o− (CFBE) cells induces a signiﬁcant increase both of
CFTR expression at the apical membrane and of the PKA-dependent activation of
chloride efﬂux. We hypothesize that this rescue of DF508CFTR-dependent chloride
secretion induced by NHERF1 over-expression could be driven by the interaction of
the actin cytoskeleton with the ezrin-NHERF1-CFTR multiprotein complex. Indeed,
confocal analysis demonstrated that normal 16HBE14o− (HBE) cells have a well-
organized actin cytoskeleton, while CFBE cells have a substantial disassembly of
actin ﬁlaments. Importantly, over-expression of NHERF1 in the CFBE cells led to
an F-actin cytoskeleton reorganization into well organized stress ﬁbers on the apical
side that closely resemble the normal cells. These results suggest that an organized
cytoskeleton is critical for apical membrane CFTR expression and/or CFTR activity
and that NHERF1 has an essential role in regulating these mechanisms, possibly
through its interaction with cytoskeleton proteins such as ezrin. As only active ezrin
is able to bind to NHERF1, we analyzed the distribution of active P-T567-ezrin with
respect to total ezrin. Confocal analysis demonstrated that active ezrin colocalized
with NHERF1 at the apical membrane in HBE monolayers and in CFBE monolayers
over-expressing NHERF1 while it was mislocalized at basolateral membrane in
CFBE cell monolayers. These results were conﬁrmed by differential detergent
extraction experiments where the ratio active ezrin/total ezrin was increased in
CFBE cells transfected with NHERF1 with respect to CFBE cells. To investigate
how the association of CFTR with the multiprotein complex NHERF1-ezrin-actin
is regulated we focused our attention on the small GTPase RhoA, as RhoA has
been shown to activate ezrin. Constitutive active RhoA induced a rescue of CFTR
activity in CFBE cells while having no effect in either HBE cells or in CFBE
